← back to search

Scott R. Daigle

EduInnovation ·
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Cancer-related gene regulation, and Protein Degradation and Inhibitors.
h-index
25
citations
4,498
works
94
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia
New England Journal of Medicine 2022cited by 472position: middledoi
Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy
Clinical Cancer Research 2019cited by 75position: middledoi
SWI/SNF component <i>ARID1A</i> restrains pancreatic neoplasia formation
Gut 2018cited by 86position: middledoi
Phase 2 multicenter study of the EZH2 inhibitor tazemetostat in adults with synovial sarcoma (NCT02601950).
Journal of Clinical Oncology 2017cited by 52position: middledoi
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Blood 2016cited by 125position: middledoi
Final Report of Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Children with Relapsed or Refractory MLL-r Acute Leukemia
Blood 2016cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2016–2017)Mrinal M. Gounder · Weill Cornell Medicine2 papers (2017–2019)— · 2 papers (2016–2017)Shu Xiao · The University of Texas Southwestern Medical Center1 papers (2018–2018)Neil R. Michaud · Epizyme (United States)1 papers (2019–2019)Jen-Chieh Chuang · Southwestern Medical Center1 papers (2018–2018)Shuchi S. Pandya · National Medical Research Center of Dentistry and Maxillofacial Surgery1 papers (2022–2022)Liem H. Nguyen · Vinmec International Hospital1 papers (2018–2018)Cynthia Wetmore · American Society of Hematology1 papers (2016–2016)Lan Peng · Sun Yat-sen University1 papers (2018–2018)Xuxu Sun · Southwestern Medical Center1 papers (2018–2018)— · 1 papers (2016–2016)Andre C. Schuh · Princess Margaret Cancer Centre1 papers (2022–2022)Nigel J. Waters · Novartis (Switzerland)1 papers (2016–2016)Pau Montesinos · Hospital Universitari i Politècnic La Fe1 papers (2022–2022)— · 1 papers (2017–2017)Patrick A. Brown · Haemonetics (United States)1 papers (2016–2016)Rodrigo T. Calado · Universidade de Ribeirão Preto1 papers (2022–2022)Christian Récher · Centre National de la Recherche Scientifique1 papers (2022–2022)Scott A. Armstrong · Harvard University1 papers (2016–2016)